ישראל -
עברית -
Ministry of Health
פלוטין 20
teva israel ltd - fluoxetine as hydrochloride - קפסולות - fluoxetine as hydrochloride 20 mg - fluoxetine - fluoxetine - treatment of depression. obsessive-compulsive disorders (ocd). flutine is also indicated for the treatment of binge-eating and vomiting behaviors in bulimia nervosa.
ישראל -
עברית -
Ministry of Health
סימבאלתה 30 מג
eli lilly israel ltd, israel - duloxetine as hydrochloride - duloxetine as hydrochloride 30 mg - duloxetine
ישראל -
עברית -
Ministry of Health
סימבאלתה 60 מג
eli lilly israel ltd, israel - duloxetine as hydrochloride - duloxetine as hydrochloride 60 mg - duloxetine
ישראל -
עברית -
Ministry of Health
פרוזק
eli lilly israel ltd, israel - fluoxetine as hydrochloride - קפסולות - fluoxetine as hydrochloride 20 mg - fluoxetine
ישראל -
עברית -
Ministry of Health
דולוקס טבע 30 מג
abic marketing ltd, israel - duloxetine as hydrochloride - duloxetine as hydrochloride 30 mg - duloxetine
ישראל -
עברית -
Ministry of Health
דולוקס טבע 60 מג
abic marketing ltd, israel - duloxetine as hydrochloride - duloxetine as hydrochloride 60 mg - duloxetine
ישראל -
עברית -
Ministry of Health
דולוקסטין סנדוז 30 מג ג'י.אר.סי
novartis israel ltd - duloxetine as hydrochloride - duloxetine as hydrochloride 30 mg - duloxetine
ישראל -
עברית -
Ministry of Health
דולוקסטין סנדוז 60 מג ג'י.אר.סי
novartis israel ltd - duloxetine as hydrochloride - duloxetine as hydrochloride 60 mg - duloxetine
ישראל -
עברית -
Ministry of Health
סטאלבו 10025200 מג
inovamed pharma ltd, israel - carbidopa; entacapone; levodopa - טבליות מצופות פילם - levodopa 100 mg; carbidopa 25 mg; entacapone 200 mg - levodopa - levodopa - treatment of patients with parkinson's disease and end-of-dose motor fluctuations not stabilised on levodopa/dopa decarboxylase (ddc) inhibitor treatment.
ישראל -
עברית -
Ministry of Health
סטאלבו 5012.5200 מג
inovamed pharma ltd, israel - carbidopa; entacapone; levodopa - טבליות מצופות פילם - levodopa 50 mg; carbidopa 12.5 mg; entacapone 200 mg - levodopa and decarboxylase inhibitor - levodopa and decarboxylase inhibitor - treatment of patients with parkinson's disease and end-of-dose motor fluctuations not stabilised on levodopa/dopa decarboxylase (ddc) inhibitor treatment.